Annual CFO
-$63.68 M
-$16.32 M-34.46%
December 31, 2023
Summary
- As of February 10, 2025, RPHM annual cash flow from operations is -$63.68 million, with the most recent change of -$16.32 million (-34.46%) on December 31, 2023.
- During the last 3 years, RPHM annual CFO has fallen by -$45.15 million (-243.56%).
Performance
RPHM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$6.81 M
+$14.21 M+67.61%
June 30, 2024
Summary
- As of February 10, 2025, RPHM quarterly cash flow from operations is -$6.81 million, with the most recent change of +$14.21 million (+67.61%) on June 30, 2024.
- Over the past year, RPHM quarterly CFO has increased by +$12.95 million (+65.54%).
Performance
RPHM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$66.34 M
+$9.31 M+12.30%
June 30, 2024
Summary
- As of February 10, 2025, RPHM TTM cash flow from operations is -$66.34 million, with the most recent change of +$9.31 million (+12.30%) on June 30, 2024.
- Over the past year, RPHM TTM CFO has dropped by -$2.66 million (-4.18%).
Performance
RPHM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RPHM Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.5% | +65.5% | -4.2% |
| 3 y3 years | -243.6% | +43.1% | -63.2% |
| 5 y5 years | -409.1% | +20.8% | -192.5% |
RPHM Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +67.7% | at low | at high | +208.7% | +74.7% | +14.0% |
| 5 y | 5-year | +409.0% | at low | +131.8% | +208.7% | +1391.8% | +14.0% |
| alltime | all time | +409.0% | at low | +131.8% | +208.7% | +1391.8% | +14.0% |
Reneo Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$6.81 M(-67.6%) | -$66.34 M(-12.3%) |
| Mar 2024 | - | -$21.01 M(+6.4%) | -$75.65 M(+18.8%) |
| Dec 2023 | -$63.68 M(+34.5%) | -$19.75 M(+5.3%) | -$63.68 M(+7.0%) |
| Sep 2023 | - | -$18.77 M(+16.5%) | -$59.54 M(+15.5%) |
| Jun 2023 | - | -$16.11 M(+78.1%) | -$51.57 M(+8.8%) |
| Mar 2023 | - | -$9.05 M(-42.0%) | -$47.41 M(+0.1%) |
| Dec 2022 | -$47.36 M(+24.7%) | -$15.61 M(+44.6%) | -$47.36 M(+13.4%) |
| Sep 2022 | - | -$10.79 M(-9.7%) | -$41.77 M(+2.8%) |
| Jun 2022 | - | -$11.96 M(+32.9%) | -$40.65 M(+5.9%) |
| Mar 2022 | - | -$9.00 M(-10.2%) | -$38.39 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$37.98 M(+104.9%) | -$10.02 M(+3.6%) | -$37.98 M(+13.8%) |
| Sep 2021 | - | -$9.67 M(-0.3%) | -$33.37 M(+13.4%) |
| Jun 2021 | - | -$9.70 M(+12.9%) | -$29.44 M(+29.8%) |
| Mar 2021 | - | -$8.59 M(+58.7%) | -$22.68 M(+22.3%) |
| Dec 2020 | -$18.54 M(+48.2%) | - | - |
| Dec 2020 | - | -$5.41 M(-5.7%) | -$18.54 M(+41.2%) |
| Sep 2020 | - | -$5.74 M(+95.5%) | -$13.13 M(+77.7%) |
| Jun 2020 | - | -$2.94 M(-34.0%) | -$7.38 M(+66.0%) |
| Mar 2020 | - | -$4.45 M | -$4.45 M |
| Dec 2019 | -$12.51 M | - | - |
FAQ
- What is Reneo Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals annual CFO year-on-year change?
- What is Reneo Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals quarterly CFO year-on-year change?
- What is Reneo Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals TTM CFO year-on-year change?
What is Reneo Pharmaceuticals annual cash flow from operations?
The current annual CFO of RPHM is -$63.68 M
What is the all time high annual CFO for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high annual cash flow from operations is -$12.51 M
What is Reneo Pharmaceuticals annual CFO year-on-year change?
Over the past year, RPHM annual cash flow from operations has changed by -$16.32 M (-34.46%)
What is Reneo Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of RPHM is -$6.81 M
What is the all time high quarterly CFO for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high quarterly cash flow from operations is -$2.94 M
What is Reneo Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, RPHM quarterly cash flow from operations has changed by +$12.95 M (+65.54%)
What is Reneo Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of RPHM is -$66.34 M
What is the all time high TTM CFO for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high TTM cash flow from operations is -$4.45 M
What is Reneo Pharmaceuticals TTM CFO year-on-year change?
Over the past year, RPHM TTM cash flow from operations has changed by -$2.66 M (-4.18%)